Oncology Medical News about Thrombocytopenia Thrombocytopenia, Neonatal Alloimmune

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09

Trebo MM et al. – Subcutaneous (sc) administration of anti–d seems to offer the same efficacy as intravenous administration but with less side effects. Here the authors report the experience with sc anti–d for pediatric immune thrombocytopenia (ITP). SC anti–d is not only an efficient means of treating ITP in children but is also a safe and convenient one.

<< Previous
Initial cytoreductive treatment with thalidomide plus bolus...

Next >>
Optimizing the management of metastatic colorectal cancer